Skip to main content
OpenTrials

Clinical trial condition

Crohn Disease

Explore clinical trials studying Crohn Disease. Study availability and eligibility vary by location and protocol.

1,338 public trials 287 recruiting studies
Refine in advanced search Browse all conditions

Crohn Disease trial results

Recruiting

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

NCT03816345

Conditions
Arthritis, Arthritis, Psoriatic, Arthritis, Rheumatoid, +59 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
View all 52 locations
View Trial Details
Recruiting

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

NCT06226883

Conditions
Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
Locations
  • Gastro Care Institute Lancaster, California, United States
  • Infinity Clinical Research San Diego, California, United States
  • Peak Gastroenterology Associates - Colorado Springs Colorado Springs, Colorado, United States
  • Clinical Research of Osceola Kissimmee, Florida, United States
View all 225 locations
View Trial Details
Recruiting

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

NCT04844606

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +11 more
Locations
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • Connecticut Children's Medical Center Hartford, Connecticut, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Children's Center for Digestive Health Care, LLC Atlanta, Georgia, United States
View all 69 locations
View Trial Details
Recruiting

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

NCT07483073

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Mayo Clinic in Arizona - Scottsdale Scottsdale, Arizona, United States
  • Biopharma Informatic, LLC Los Angeles, California, United States
  • Om Research LLC Oxnard, California, United States
  • South Denver Gastroenterology Englewood, Colorado, United States
View all 70 locations
View Trial Details
Recruiting

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

NCT07483099

Conditions
Crohn Disease, Digestive System Diseases, Gastroenteritis, +3 more
Locations
  • Mayo Clinic in Arizona - Scottsdale Scottsdale, Arizona, United States
  • Biopharma Informatic, LLC Los Angeles, California, United States
  • Om Research LLC Oxnard, California, United States
  • South Denver Gastroenterology Englewood, Colorado, United States
View all 70 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

NCT06430801

Conditions
Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
Locations
  • Digestive Health Specialists ( Site 5064) Dothan, Alabama, United States
  • Arizona Arthritis & Rheumatology Research, PC ( Site 5094) Phoenix, Arizona, United States
  • GI Alliance - Sun City ( Site 5118) Sun City, Arizona, United States
  • University of Arizona Clinical and Translational Sciences Research Center ( Site 5111) Tucson, Arizona, United States
View all 499 locations
View Trial Details

Related conditions